Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
Clinical trial NCT01826214 · COMPLETED
Trial details
- NCT number
- NCT01826214
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.